GO:0002663 positive regulation of B cell tolerance induction: Immune Tolerance Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002663 describes any process that activates or increases the frequency, rate, or extent of B cell tolerance induction, a critical safeguard against autoimmunity.
• B cell tolerance induction involves both central and peripheral mechanisms, including receptor editing, anergy, and deletion, and is positively regulated by factors such as Bcl-2, CD80, and regulatory T cells.
• Dysregulation of positive regulation of B cell tolerance induction is linked to autoimmune diseases like multiple sclerosis and systemic lupus erythematosus, as well as lymphomas.
• Key genes and proteins in this process include BCL2, CD80, CTLA4, CD45, TIM-1 (HAVCR1), TIGIT, and MHC class II molecules.
• Experimental models for studying this term include knockout mice, knock-in reporters, and overexpression systems, often combined with CRISPR screening.
• EDITGENE provides CRISPR-based services to dissect the genetic control of B cell tolerance, from knockout to library screening.
Description
Positive regulation of B cell tolerance induction (GO:0002663) is a biological process that enhances the mechanisms by which B lymphocytes become unresponsive to self-antigens, thereby preventing autoimmunity. This process is essential for maintaining immune homeostasis and is orchestrated by a complex interplay of cell surface receptors, signaling molecules, and transcriptional programs. Understanding how B cell tolerance is positively regulated offers insights into the pathogenesis of autoimmune diseases and informs the development of targeted therapies. Researchers studying this term investigate the molecular and cellular events that boost tolerance induction, such as the role of Bcl-2 in promoting B cell survival and tolerance, or the influence of CD80 expression on T cell autoreactivity. The QuickGO definition states that GO:0002663 encompasses any process that activates or increases the frequency, rate, or extent of B cell tolerance induction. This article synthesizes current knowledge from authoritative literature to provide a comprehensive overview of the mechanisms, genes, and research methodologies associated with this critical immune regulatory process.
positive regulation of B cell tolerance induction At A Glance
| GO ID | GO:0002663 |
|---|---|
| GO term | positive regulation of B cell tolerance induction |
| Ontology | biological_process |
| Synonym | activation of B cell tolerance induction; positive regulation of B-cell tolerance induction; positive regulation of B lymphocyte tolerance induction; positive regulation of B-lymphocyte tolerance induction; stimulation of B cell tolerance induction; up regulation of B cell tolerance induction; up-regulation of B cell tolerance induction; upregulation of B cell tolerance induction |
| Major function | Enhances the induction of B cell tolerance, preventing autoimmunity |
| Related processes | B cell anergy, receptor editing, clonal deletion, regulatory B cell function |
| Key regulators | BCL2, CD80, CTLA4, CD45, TIM-1, TIGIT, MHC class II |
| Disease relevance | Autoimmune diseases (multiple sclerosis, lupus), lymphomas |
What Is GO:0002663?
GO:0002663, positive regulation of B cell tolerance induction, refers to any biological process that activates or increases the frequency, rate, or extent of B cell tolerance induction. In other words, it covers the signals and mechanisms that enhance the ability of B cells to become tolerant to self-antigens, thereby preventing autoimmune responses.
Why Is positive regulation of B cell tolerance induction Important in Cell Biology?
Positive regulation of B cell tolerance induction is crucial for preventing autoimmunity, as it ensures that B cells that recognize self-antigens are either eliminated, rendered anergic, or their receptors are edited to remove self-reactivity. Defects in this process can lead to the escape of autoreactive B cells, contributing to diseases such as multiple sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. Moreover, understanding how B cell tolerance is positively regulated can inform the development of novel therapies for autoimmune diseases and improve vaccine design.
• Prevents autoimmunity by eliminating or silencing self-reactive B cells.
• Dysregulation is linked to autoimmune diseases like multiple sclerosis.
• Bcl-2 overexpression in B cells cooperates with p21 deficiency to induce autoimmunity and lymphomas.
• CD80 expression on B cells regulates T cell autoreactivity to MHC class II.
• Regulatory T cells induced via mucosal routes can promote B cell tolerance.
• Mannose receptor induces T-cell tolerance via inhibition of CD45 and up-regulation of CTLA-4.
• B cell tolerance is essential for successful allergen-specific immunotherapy.
• TIM-1 and TIGIT define human regulatory memory B cells that are dysfunctional in multiple sclerosis.
• Understanding positive regulation can guide development of tolerance-inducing therapies.
• CRISPR screening can identify novel regulators of B cell tolerance.
What Happens During positive regulation of B cell tolerance induction?
Central Tolerance and Receptor Editing
In simple terms: In the bone marrow, developing B cells that recognize self-antigens can change their receptors to avoid attacking the body.
Central B cell tolerance is established in the bone marrow, where self-reactive B cells undergo receptor editing, anergy, or deletion. Positive regulation of this process enhances the efficiency of these mechanisms, ensuring that autoreactive B cells are removed from the repertoire. For example, Bcl-2 overexpression in B cells can promote survival and potentially influence tolerance induction, as shown in a mouse model where Bcl-2 cooperated with p21 deficiency to induce autoimmunity and lymphomas.
Peripheral Tolerance and Anergy
In simple terms: In the bloodstream and lymph nodes, mature B cells that react to self-antigens can be turned off or made unresponsive.
Peripheral tolerance mechanisms, including anergy and suppression by regulatory T cells, are critical for maintaining B cell unresponsiveness to self. Positive regulation of B cell tolerance induction in the periphery involves interactions with regulatory T cells and cytokines. For instance, CD4+ T-cell anergy and apoptosis can be induced by activated human B cells, suggesting a bidirectional regulation. Additionally, mannose receptor induces T-cell tolerance via inhibition of CD45 and up-regulation of CTLA-4, which may indirectly promote B cell tolerance.
Role of Regulatory B Cells
In simple terms: Some B cells can suppress immune responses and help maintain tolerance.
Regulatory B cells (Bregs) are a subset of B cells that suppress immune responses and promote tolerance. Human regulatory memory B cells defined by expression of TIM-1 and TIGIT are dysfunctional in multiple sclerosis, highlighting their importance in maintaining tolerance. Positive regulation of B cell tolerance induction may involve the expansion or activation of Bregs, which can inhibit autoreactive T cells and B cells.
Mucosal Tolerance Induction
In simple terms: Exposure to antigens through the nose or mouth can teach the immune system to tolerate them.
Mucosal tolerance induction via nasal or oral routes can lead to antigen-specific regulatory T-cell induction, which in turn can promote B cell tolerance. This process is exploited in allergen-specific immunotherapy, where repeated exposure to allergens induces tolerance. Positive regulation of B cell tolerance induction in mucosal tissues involves the induction of regulatory T cells and the suppression of inflammatory responses.
Key Genes Involved in GO:0002663 positive regulation of B cell tolerance induction
The following genes and proteins have been implicated in the positive regulation of B cell tolerance induction, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BCL2 | Anti-apoptotic protein; promotes B cell survival | Overexpression cooperates with p21 deficiency to induce autoimmunity and lymphomas |
| CD80 | Costimulatory molecule on B cells; regulates T cell autoreactivity | Controls T cell autoreactivity to MHC class II |
| CTLA4 | Inhibitory receptor; downregulates T cell responses | Up-regulated by mannose receptor, contributing to T-cell tolerance |
| CD45 | Protein tyrosine phosphatase; regulates antigen receptor signaling | Inhibited by mannose receptor, leading to T-cell tolerance |
| HAVCR1 (TIM-1) | Cell surface receptor; defines regulatory memory B cells | Dysfunctional in multiple sclerosis |
| TIGIT | Inhibitory receptor; defines regulatory memory B cells | Dysfunctional in multiple sclerosis |
| MHC class II | Antigen presentation to CD4+ T cells | Regulated by CD80 on B cells |
| P21 (CDKN1A) | Cell cycle inhibitor | Deficiency cooperates with Bcl-2 overexpression to induce autoimmunity |
| IL-10 | Anti-inflammatory cytokine | Produced by regulatory B cells; promotes tolerance |
| TGF-beta | Anti-inflammatory cytokine | Involved in mucosal tolerance induction |
| FOXP3 | Transcription factor for regulatory T cells | Induced via mucosal routes, promoting B cell tolerance |
| CD4 | T cell co-receptor | Interacts with MHC class II on B cells |
| CD40 | Costimulatory molecule on B cells | Interacts with CD40L on T cells; influences tolerance |
| BAFF | B cell survival factor | Overexpression can break tolerance |
| APRIL | B cell survival factor | Similar to BAFF; can influence tolerance |
| IgG | Antibody isotype | Allergen-specific immunotherapy induces IgG responses |
| IgE | Antibody isotype | Targeted in allergy; tolerance induction reduces IgE |
How Is positive regulation of B cell tolerance induction Regulated?
Positive regulation of B cell tolerance induction is controlled by a network of signaling pathways and transcription factors. For example, Bcl-2 family proteins regulate B cell survival and apoptosis, influencing the stringency of tolerance checkpoints. Costimulatory molecules such as CD80 and CD40 modulate the threshold for B cell activation and tolerance. Regulatory T cells and cytokines like IL-10 and TGF-beta suppress autoreactive B cells and promote tolerance. Additionally, mannose receptor signaling inhibits CD45 and up-regulates CTLA-4, leading to T-cell tolerance that can indirectly affect B cells.
positive regulation of B cell tolerance induction and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BCL2 | Autoimmunity and lymphomas | B cell-specific Bcl-2 transgenic mice |
| P21 (CDKN1A) | Autoimmunity | p21 knockout mice crossed with Bcl-2 transgenic |
| TIM-1 (HAVCR1) | Multiple sclerosis | TIM-1 knockout or overexpression in human B cells |
| TIGIT | Multiple sclerosis | TIGIT knockout mice or human B cell cultures |
| CD80 | Autoimmune T cell responses | CD80 knockout or transgenic mice |
Multiple Sclerosis
In multiple sclerosis, human regulatory memory B cells defined by TIM-1 and TIGIT are dysfunctional, suggesting that impaired positive regulation of B cell tolerance induction contributes to disease pathogenesis. This dysfunction may lead to the expansion of autoreactive B cells that attack the central nervous system.
Autoimmunity and Lymphoma
B-cell overexpression of Bcl-2 cooperates with p21 deficiency to induce autoimmunity and lymphomas in mice, demonstrating that dysregulated survival signals can break B cell tolerance and lead to both autoimmune and malignant outcomes. This highlights the importance of balanced positive regulation of B cell tolerance induction.
Allergy and Asthma
Allergen-specific immunotherapy relies on the induction of tolerance, including B cell tolerance, to reduce allergic responses. Positive regulation of B cell tolerance induction is therefore a therapeutic goal in allergy treatment.
Primary Atopic Disorders
Rapid identification of primary atopic disorders by genomic sequencing can reveal mutations in genes that regulate B cell tolerance, such as those involved in immune dysregulation. Understanding these genetic defects can guide precision therapies.
From positive regulation of B cell tolerance induction-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate B cell tolerance? | Knockout mouse (e.g., gene X-/-) followed by autoantibody profiling |
| Does a point mutation in gene Y affect tolerance induction? | Point-mutation knock-in mouse (e.g., Y mutant) |
| Does overexpression of gene Z break tolerance? | B cell-specific overexpression transgenic mouse |
| Can we track tolerance induction in real-time? | Tagged knock-in reporter (e.g., GFP-tagged tolerance marker) |
| What is the role of gene W in human B cell tolerance? | Human primary B cell CRISPR knockout or overexpression |
| Can we identify novel regulators via high-throughput screening? | CRISPR library screening in B cell lines or primary cells |
How to Study the positive regulation of B cell tolerance induction Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Frequency and phenotype of autoreactive B cells | Assessing tolerance induction in vivo |
| CRISPR screening | Genes that regulate B cell tolerance | Discovery of novel regulators |
| Adoptive transfer | Ability of B cells to induce autoimmunity | Testing gene function in tolerance |
| Single-cell RNA-seq | Transcriptional profiles of B cell subsets | Identifying regulatory B cell signatures |
| ELISPOT | Autoantibody-secreting cells | Quantifying autoreactive B cells |
| Tetramer staining | Antigen-specific B cells | Tracking self-reactive B cells |
| Western blot | Protein expression levels | Validating knockout or overexpression |
| Immunohistochemistry | Tissue localization of B cells | Assessing tolerance in lymphoid organs |
Flow Cytometry and Tetramer Staining
Flow cytometry with self-antigen tetramers can identify autoreactive B cells and assess their frequency and phenotype in tolerance studies. This method allows researchers to track the induction of tolerance in vivo.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify genes that positively regulate B cell tolerance induction. These screens are powerful for discovering novel regulators and pathways.
Adoptive Transfer and Autoantibody Profiling
Adoptive transfer of B cells into recipient mice, followed by autoantibody profiling, can test whether a gene promotes tolerance. This method is useful for validating candidate regulators in vivo.
Single-Cell RNA Sequencing
Single-cell RNA sequencing of B cell subsets can reveal transcriptional programs associated with tolerance induction. This approach can identify regulatory B cell signatures and their dysfunction in disease.
How CRISPR Can Be Used to Study GO:0002663 positive regulation of B cell tolerance induction
Knockout
CRISPR knockout of candidate genes in B cell lines or primary B cells can determine whether they are required for positive regulation of B cell tolerance induction. For example, knocking out BCL2 or CD80 can test their role in tolerance.
Point Mutation
CRISPR point mutation can introduce specific amino acid changes to dissect functional domains of proteins involved in tolerance, such as Bcl-2 phosphorylation sites. This approach helps distinguish between different signaling outputs.
Knock-in
CRISPR knock-in can insert reporter genes (e.g., GFP) or epitope tags into endogenous loci to track expression and localization of tolerance regulators in real-time. This is useful for studying dynamic processes.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression can elevate gene expression to test whether a gene is sufficient to enhance B cell tolerance induction. Overexpression of Bcl-2 in B cells, for example, promotes survival and can influence tolerance.
How EDITGENE Supports positive regulation of B cell tolerance induction Research
Researchers studying positive regulation of B cell tolerance induction-related genes often need to determine whether a candidate gene is causally involved in tolerance or merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such functional studies, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of B cell tolerance induction research.
Frequently Asked Questions About positive regulation of B cell tolerance induction
What is GO:0002663?
GO:0002663 is the Gene Ontology term for positive regulation of B cell tolerance induction, a biological process that enhances the mechanisms by which B cells become tolerant to self-antigens.
What genes are involved in positive regulation of B cell tolerance induction?
Key genes include BCL2, CD80, CTLA4, CD45, TIM-1 (HAVCR1), TIGIT, and MHC class II, among others.
How is B cell tolerance induced?
B cell tolerance is induced through central and peripheral mechanisms, including receptor editing, anergy, deletion, and suppression by regulatory T cells and regulatory B cells.
What diseases are associated with defective B cell tolerance?
Defective B cell tolerance is associated with autoimmune diseases such as multiple sclerosis, systemic lupus erythematosus, and lymphomas.
What is the role of Bcl-2 in B cell tolerance?
Bcl-2 promotes B cell survival and can cooperate with p21 deficiency to induce autoimmunity and lymphomas, indicating its involvement in tolerance regulation.
How does CD80 on B cells regulate tolerance?
CD80 on B cells regulates T cell autoreactivity to MHC class II, influencing the induction of tolerance.
What are regulatory B cells?
Regulatory B cells are a subset of B cells that suppress immune responses and promote tolerance, often defined by markers like TIM-1 and TIGIT.
Can CRISPR be used to study B cell tolerance?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression can be used to dissect gene function in B cell tolerance induction.
What is the role of mannose receptor in tolerance?
Mannose receptor induces T-cell tolerance via inhibition of CD45 and up-regulation of CTLA-4, which may indirectly promote B cell tolerance.
How does allergen immunotherapy relate to B cell tolerance?
Allergen-specific immunotherapy induces tolerance, including B cell tolerance, to reduce allergic responses.
Conclusion
Positive regulation of B cell tolerance induction (GO:0002663) is a vital process that safeguards against autoimmunity by enhancing the mechanisms that silence self-reactive B cells. Key genes such as BCL2, CD80, and TIM-1 play critical roles, and their dysregulation is linked to diseases like multiple sclerosis and lymphoma. Advances in CRISPR-based models and screening technologies are accelerating the discovery of novel regulators and therapeutic targets. EDITGENE offers a comprehensive suite of services to support research in this field, from gene editing to bioinformatics.
References
- 1. Niehues T et al.. 2024. Rapid identification of primary atopic disorders (PAD) by a clinical landmark-guided, upfront use of genomic sequencing.. Allergol Select 8:304-323 PMID: 39381601
- 2. Varghese JF et al.. 2024. Human regulatory memory B cells defined by expression of TIM-1 and TIGIT are dysfunctional in multiple sclerosis.. Front Immunol 15:1360219 PMID: 38745667
- 3. Tretter T et al.. 2008. Induction of CD4+ T-cell anergy and apoptosis by activated human B cells.. Blood 112(12):4555-64 PMID: 18802006
- 4. Akdis CA et al.. 2011. Mechanisms of allergen-specific immunotherapy.. J Allergy Clin Immunol 127(1):18-27; quiz 28-9 PMID: 21211639
- 5. Samsom JN. 2004. Regulation of antigen-specific regulatory T-cell induction via nasal and oral mucosa.. Crit Rev Immunol 24(3):157-77 PMID: 15482252
- 6. Santiuste I et al.. 2010. B-cell overexpression of Bcl-2 cooperates with p21 deficiency for the induction of autoimmunity and lymphomas.. J Autoimmun 35(4):316-24 PMID: 20691570
- 7. Schuette V et al.. 2016. Mannose receptor induces T-cell tolerance via inhibition of CD45 and up-regulation of CTLA-4.. Proc Natl Acad Sci U S A 113(38):10649-54 PMID: 27601670
- 8. Hasegawa A et al.. 1998. Regulation of T cell autoreactivity to MHC class II by controlling CD80 (B7-1) expression on B cells.. Int Immunol 10(2):147-58 PMID: 9533442
